The adverse consequences of obesity are much more complex than simply being an imbalance between energy intake and energy output. Learn the pathophysiology behind this epidemic and how to diagnose and treat this multifactorial disease.
DyslipidemiaManagementPharmacotherapyElevated triglyceride and reduced high-density lipoprotein cholesterol (HDL-C) are common in type 2 diabetes, but increased atherogenic particles and dysfunctional HDL are demonstrable in both types 1 and 2 diabetes, contributing to a two-fold increase in atherosclerotic...
Learning Objectives: At the conclusion of this activity, participants should be able to: Review the evidence about the pathogenesis of HIV-associated lipodystrophy, including pathogenic influences associated with host, disease, and treatment-related factors. Diagnose ...
intheirabilitytodiagnoseandtargetthe so-calledatherogenicdyslipidemia(high- densitylipoprotein[HDL-C]levels[50 mg/dLinwomen,40mg/dLinmen] coupledwithhightriglycerideconcen- trations[ 150mg/dL]. Themosteffectivewaytoinitiatea preventivecardiacprogramistoiden- ...
Learn how to diagnose hypertension. Blood pressure varies regularly throughout the day. It is lower when you sleep and rest, and rises if you are excited, nervous, or active. For this reason, diagnosis of abnormal blood pressure is made only when elevated blood pressure is seen during at le...
A high total serum cholesterol is the key to case finding; levels of the major classes of lipoproteins may guide management of patients at risk. The cornerstone of therapy is a diet low in saturated fats and cholesterol. If that proves inadequate, drugs may be selected from the increasing ...
Evaluation and treatment of the associated lipid and lipoprotein abnormalities is a common consideration in the management of these patients. Here, I discuss my usual approach to dealing with dyslipidemia in patients with diabetes. Screening for Dyslipidemias The Adult Treatment Panel II recommendations ...
How should we treat hypertension and dyslipidemia in patients with prediabetes?. Tsimihodimos V,Florentin M,Elisaf MS. Current Pharmaceutical Design . 2013Tsimihodimos V, Florentin M, S Elisaf M. How should we treat hypertension and dyslipidemia in patients with predia-betes?[J]. Curt Pharm ...
How We Treat Dyslipidemia in Prolonged Nephrotic Syndromelipidsnephrotic syndromepharmacologydoi:10.2215/CJN.0000000000000514Ponticelli, ClaudioArnaboldi, LorenzoMoroni, GabriellaFornoni, AlessiaAmerican Society of NephrologyClinical Journal of the American Society of Nephrology...